Initial Management of Acute Asthma Exacerbation
For a patient presenting with an acute asthma exacerbation, immediately administer supplemental oxygen to maintain SaO₂ >92%, repetitive or continuous short-acting beta-2 agonist (SABA) bronchodilators, and oral systemic corticosteroids, while simultaneously assessing severity through lung function measurement and clinical parameters. 1
Immediate Assessment and Triage
Assess severity immediately upon presentation using the following parameters:
- Lung function: Measure FEV₁ or peak expiratory flow (PEF) as the primary determinant of exacerbation severity 1
- Clinical signs of severe/life-threatening exacerbation: Look for inability to speak in full sentences, use of accessory muscles, paradoxical thoracoabdominal movement, altered mental status, cyanosis, or "silent chest" on auscultation 1
- Vital signs: Assess respiratory rate, heart rate, oxygen saturation, and blood pressure 1
- Brief history: Document time of onset, triggers, current medications and timing of last dose, previous severe exacerbations (especially those requiring intubation or ICU admission), and response to any pre-hospital treatment 1
Initial Treatment Protocol
Oxygen Therapy
- Administer supplemental oxygen immediately to all patients with acute exacerbation to maintain SaO₂ >92% 1, 2
Bronchodilator Therapy
- Give SABA repetitively or continuously: Albuterol 5-10 mg via nebulizer every 15-30 minutes for the first hour, or continuous nebulization for severe exacerbations 1, 2
- Add ipratropium bromide 0.5 mg nebulized every 20 minutes for 3 doses if not already given, then every 6 hours for severe exacerbations (FEV₁ or PEF <40% predicted) 1, 2
Systemic Corticosteroids
- Administer oral systemic corticosteroids immediately: Give 30-60 mg prednisolone (or equivalent) in adults, or 1-2 mg/kg body weight in children 1, 2
- Continue this dose each morning until two days after control is established 1
- Intravenous route: Use hydrocortisone 200 mg every 6 hours if oral route is not feasible 2
Severity-Based Treatment Adjustments
For Severe Exacerbations (FEV₁ or PEF <40% predicted)
- Consider adjunctive therapies if unresponsive to initial treatment within 1 hour:
Monitoring Response
- Reassess every 15-30 minutes initially with serial PEF or FEV₁ measurements 2
- Continuous pulse oximetry to maintain SaO₂ >92% 2
- Arterial blood gas if initial PaO₂ <60 mmHg or if patient deteriorates, watching for rising PaCO₂ as a sign of impending respiratory failure 2
Critical Decision Points
ICU Transfer Criteria
Transfer to ICU immediately if any of the following occur:
- Deterioration or failure to improve rapidly after 1 hour of intensive treatment 2
- Continued respiratory distress after initial bronchodilators and systemic corticosteroids 2
- Signs of impending respiratory failure: exhaustion, confusion, rising PaCO₂ 2
- History of near-fatal asthma requiring intubation 2
Common Pitfalls to Avoid
- Never administer sedatives to patients with acute asthma, as this can precipitate respiratory arrest 2
- Do not delay ICU transfer in deteriorating patients, as this increases mortality risk 2
- Avoid relying solely on wheezing as an indicator of severity; absence of wheezing ("silent chest") may indicate severe obstruction 1
- Do not use SABA alone without systemic corticosteroids in moderate-to-severe exacerbations 1
Disposition Planning
If Responding to Treatment
- Continue monitoring for at least 1-2 hours after initial treatment 1
- Patients who continue to meet criteria for severe exacerbation after 1-2 hours have >84% chance of requiring hospitalization 2
At Discharge (if appropriate)
- Prescribe oral systemic corticosteroids to continue at home 1
- Initiate or optimize inhaled corticosteroids (ICS) 1
- Provide SABA for rescue use 1
- Review inhaler technique and provide written asthma action plan 1
- Arrange follow-up within 2-4 weeks 3
Risk Factors Requiring Closer Monitoring
Identify patients at high risk for asthma-related death:
- Previous severe exacerbation requiring intubation or ICU admission 1
- Two or more hospitalizations or three or more ED visits for asthma in the past year 1
- Using >2 canisters of SABA per month 1
- Lack of written asthma action plan 1
- Low socioeconomic status, illicit drug use, or major psychosocial problems 1
- Cardiovascular disease or other chronic comorbidities 1